All right, so getting into the medications today, drug at number 51, the brand name is Lunesta.

Generic name is Azopaclone.

Its mechanism of action is it binds to and potentiates the effect of gamma receptors leading to a sedative type effect.

So, as you can imagine, this medication is

classified as a sleeper or a sedative type agent. Again, falls under the classification of a

Z drug because the generic name has a Z in it and it's for sleep. So that's a good kind of classification to remember if you're being tested on that.

And mechanistically, it works very similar to benzodiazepines.

So as you could expect, we are going to have a very, very similar adverse effect profile.

So dizziness, confusion, obviously sedation, that's generally what we're trying to do there.

Increased risk for falls, particularly in the elderly.

Also, you know, associated with most of the sleeping medications, we can have some rare sleep-type

side effects.

And the Z-drugs are specifically notorious for this.

Sleep-walking, sleep-eating, kind of these unique and abnormal sleeping-type behaviors.

In addition to that, vivid or bad dreams are possible.

This is definitely something I've heard patients report.

There is a risk of addiction and dependence with these agents.

So they are a controlled substance and they are scheduled for there.

So with Lunesta specifically, I keep an eye out for patients who are using this long term.

Obviously, like to try to get them off of a controlled substance long term, if at all possible.

Do your best limit dose, so minimize that risk for falls and confusion and other kind of

collateral damage. And then, of course, making sure that we're tapering periodically or

...